PANEL DISCUSSION: TOKEN OFFERINGS AND FINANCING OF BLOCKCHAIN STARTUPS AND INITIATIVES

  • Token taxonomy
  • Regulatory environment for tokens
    • SEC DAO report July 2017
    • SEC compliant token offerings (Reg S, Reg D, Reg A, etc.)
    • Tokens regulated as commodities
    • Tokens regulated through money transmission laws (FinCen)
    • State regulatory issues
  • There are currently are 120+ healthcare token offerings. How would you characterize these?
  • Impact of token offerings on healthcare
  • Which among healthcare token offerings do you see as either getting early traction or having the potential for early traction? What are they doing right?
  • What are some of the biggest mistakes that you’re seeing healthcare token issuers make?

Moderator:
Alan Gilbert, MPA, FHIMSS, Chief Growth Officer, V3 Health Strategy
Panelists:
Michael Dillhyon, Founder, healthbank
Michelle Gitlitz, Partner, Blank Rome LLP
Katherine Kuzmeskas, MPH, Founder & CEO, SimplyVital Health
Robert Miller, Director of Business Development, Medicalchain
Adi Segal, CoFounder & CEO, SeeThru